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ABSTRACT 
Objective: The investigation has been conducted to find out the threshold dose of ethyl acetate fraction prepared from aqueous-methanol (40:60) 
extract of seed of Myristica fragrans (Houtt.) from the dose dependent experiment by noting the remedial effects of the said fraction on different 
complications developed in streptozotocin induced diabetic rat. 
Methods: Diabetic condition was made by single intramascular injection of streptozotocin at a dose of 4 mg/0.1 ml citrate buffer/100 g body 
weight. Treatment was conducted at different doses for 28 d on diabetic rat. Efficacy of the fraction on fasting blood glucose (FBG) and serum 
insulin levels, activities of key carbohydrate metabolic enzymes such as hexokinase, glucose-6-phosphate dehydogenase, glucose-6-phosphatase of 
hepatic and skeletomuscular tissue as well as antioxidative enzymes like catalase, superoxide dismutase (SOD) in connection with the levels of 
oxidative stress end products such as thiobarbituric acid reactive substances (TBARS), conjugated diene (CD) in hepatic and renal tissue and gene 
expression of hexokinase-1, SOD, Bax, Bcl-2 in hepatic tissue were assessed. 
Results: After different doses of fraction treatment to the diabetic animals; FBG, serum insulin levels and activities of carbohydrate metabolic 
enzymes i.e. hexokinase, glucose-6-phosphate dehydrogenase and glucose-6-phosphatase were rectified towards the control at the level of p<0.05. 
There is a significant (p<0.05) recovery in the activities of antioxidant enzymes such as catalase and SOD in respect to the vehicle treated diabetic 
group. Oxidative stress end products such as CD and TBARS levels were increased significantly (p<0.05) in vehicle treated diabetic rats and was 
rectified significantly (p<0.05) after fraction treatment at the dose of 10 mg or 20 mg or 40 mg fraction treated group. Gene expression of 
hexokinase-1, superoxide dismutase, bax and bcl-2 was rectified towards vehicle treated control significantly at the level of p<0.05 after treatment 
of different doses of fractions to the diabetic animals. 
Conclusion: The study indicates that the seeds of Myristica fragrans at the dose of 20 mg/100 g body weight possess most effective outcome to 
manage diabetic disorders in streptozotocin induced diabetic rats. 
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Diabetes mellitus has been termed as a set of metabolic dysfunctions 
associated with chronic hyperglycemia due to impaired secretion and/or 
action of insulin which results in distortion in the metabolism of 
carbohydrate, fat and protein [1, 2]. Diabetes mellitus has been 
established to be high level of oxidative stress injury and accordingly an 
variation in the body’s antioxidant defense system [3, 4]. It is a common 
metabolic disorder with micro-and macrovascular complication that 
results morbidity and mortality. It is consider as one of the five leading 
reason of death in the world [5, 6]. A number of man-made drugs such as 
glibenclamide, biguanide and sulfonylurea are now available to diminish 
the threat of diabetes mellitus but these drugs causes side effects [7]. As 
a consequence, there is a need to explore a new class of remedial 
compounds to defeat those problems [8]. The world health organization 
(WHO) recommended the consideration of plant and folk medicine for 
management of some diseases [9]. From the literature review, over 800 
plants species have been noted with antidiabetic efficacy [10]. Various 
native remedial plants and extracts from different parts of these plants 
like root, leaf, flower, seed etc. have been [11-13] investigated for the 
management of diabetes. 
Nutmeg (Myristica fragrans Houtt.), a tropical evergreen tree is the 
source of the high rate healing spices, nutmeg (endosperm) and 
mace (the reddish aril) with massive phytochemical variety [14]. 
Current information on its anti-diabetic, anti-leukaemic, anti-
bacterial, anti-viral effects and other biological activities [14-16] 
specify its massive beneficial potential. 
There is no complete work regarding the anti-diabetic and anti-
oxidative activities of the seed of Myristica fragrans (M. fragrans) 
from the standpoint of biochemical and molecular studies. Hence, 
the present study has been conducted to explore the effective dose 
of ethyl-acetate fraction of aqueous-methanolic (40:60) extract of 
seed of M. fragrans in streptozotocin induced diabetic male rat with 
special reference to correction of carbohydrate metabolic disorders 
from genomic point of view. 
MATERIALS AND METHODS 
Preparation of ethyl acetate fractionation from aqueous-
methanol (40:60) extract of seed of M. fragrans 
The seeds of M. fragrans were collected (August-September, 2015) 
from the local market place of Paschim Medinipore town, 
Midnapore, West Bengal, India and identified by Prof. Ram Kumar 
Bhakat, taxonomist in the Department of Botany and Forestry, 
Vidyasagar University, Midnapore. The voucher specimen was 
preserved there, having Ref. No.-(BMLSM-11/2016). Extraction and 
fractionation of seed was done by standard as per our earlier report 
[17]. This fraction residue was suspended in tween 80 and water at 
a ratio of 1:19, which was used for treatment. 
Selection of animal and animal care 
This investigational work was conducted by using thirty matured 
Wistar strain normoglycemic male albino rats, age near about 3 mo, 
weighing about 100±10g, six rats were housed in each hygienic and 
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dry polypropylene made cage. Earlier to conducting the tests, all rats 
were acclimated for 15 d in laboratory situation. Standard atmosphere 
in the animal house was maintained with dark-light cycle (12h: 12h) 
and room temperature at 28±2 °C with 45%-60% humidity. Each rat 
had open access to standard food as well as water ad libitum for 
specific period. The principle of laboratory animal care and instruction 
given by our Institutional Ethic Committee (IEC) [IEC/9/2/18, dated 
02/02/2018] were followed during the experiment. 
Chemicals 
Sigma, USA made streptozotocin (STZ) was purchased for the 
conduction of research work. Other chemicals like adenosine tri 
phosphate (ATP), nicotinamide adenine dinucleotide phosphate (NADP), 
2-[4-(2-hydroxyethyl) 1-piperazinyl] ethane sulphonic acid (HEPES) 
were used from Sigma-Aldrich Diagnostic Ltd. or Sisco Research 
Laboratory (SRL), India. Kits for the assessment of serum insulin level 
was purchased from RayBiotech, Norcross, USA. Isolation kit from RNA 
and ‘Transcriptor first strand cDNA synthesis kit’ were purchased from 
Roche Diagnostic, Mannheiem, Germany for real time PCR study.  
Induction of diabetes mellitus in rat 
In connection to our prior work, the projected dose of streptozotocin 
(STZ) which generates diabetic state in adult rat was selected [18]. 
In concise, overnight fasted rats were subjected to a single 
intramuscular injection of STZ at the dose of 4 mg/0.1 ml of citrate 
buffer/100 g body weight/rat that generate diabetes. The fasting 
blood glucose (FBG) level was in between 300-340 mg/dl after 48h 
of STZ injection. After the 7th day of STZ injection, the FBG level was 
measured once more to observe the constancy of the diabetic state. 
In this approach, twenty four rats were made as diabetic.  
Animal treatment 
Five homogeneous groups were prepared by using thirty rats. Ethyl 
acetate fraction of aqueous-methanol (40:60) extract of seed of M. 
fragrans was given from the 7th day of post injection phase of STZ and 
was considered as 1st day of treatment. The duration of treatment was 
28 d. 
The rats were alienated as follows into five groups:  
Group-I: Vehicle treated control: (Received 0.5 ml of 3.0% Tween 
80/100 g body weight/day). 
Group-II: Vehicle treated diabetic: (Received 0.5 ml of 3.0% 
Tween 80/100 g body weight/day).  
Group-III: Ethyl acetate fraction 10 mg: (Received 10 mg/0.5 ml 
of 3.0% Tween 80/100 g body weight/day). 
Group-IV: Ethyl acetate fraction 20 mg: (Received 20 mg/0.5 ml 
of 3.0% Tween 80/100 g body weight/day). 
Group-V: Ethyl acetate fraction 40 mg: (Received 40 mg/0.5 ml of 
3.0% Tween 80/100 g body weight/day). 
Every day, the oral dose of the above-mentioned fraction was given 
to the overnight fasted rats in the morning (at 11:00 am). After 2 h of 
fraction treatment; food was given to the rats. The feed box was 
cleaned in the evening (at 7:00 pm). By using single touch 
glucometer, fasting blood glucose (FBG) level was measured in all 
the groups on every 7th d [19]. 
Treatment of fraction or vehicle to the animals was performed by forced 
feeding with gavage. On 29th day of experiment considering treatment 
of fraction as 1st day of the experiment schedule, all the animals were 
sacrificed at fasting state by euthanasia followed by decapitation after 
recording the final body weight. Blood was collected from dorsal aorta 
by a syringe and the serum was separated by centrifugation for the 
measurement of insulin level. The liver, kidney, skeletal muscle 
(Gastrocnemius) were dissected out and stored at-20 °C for the 
measurement of different relevant parameters in this concern. Pancreas 
was collected and was placed in Bouin’s fluid for histological analysis. 
Measurement of FBG level 
At the grouping time of all the animals, FBG level was measured. 
Further FBG levels were recorded throughout the experiment at 7 d 
of interval. Blood was collected from the tail vein by syringe 
following warm up the tail. Single touch glucometer was used for the 
measurement of FBG level [19]. 
Assay of serum insulin 
Serum insulin level was measured using solid phase conjugated 
sandwitch ELISA kit for rat. The level of insulin was expressed in 
terms of µIU/ml [20]. 
Assay of hexokinase activity  
In a spectrophotometer cuvette 0.9 ml of assay mixture (3.7 mmol 
glucose, 7.5 mmol MgCl2, 11 mmol thioglycerol and 45 mmol HEPES, pH 
7.5), 0.01 ml glucose-6-phosphate dehydrogenase, 0.01 ml NADP and 
0.03 ml ATP were added and mixed well. To it 0.6 ml of tissue 
supernatant was added to the cuvette and mixed immediately, then read 
at 340 nm. The subsequent six readings were recorded at 30 sec interval. 
The enzyme activity was determined on the basis of reduction of NADPH 
which was measured spectrophotometrically at 340 nm. One unit of 
hexokinase activity was expressed in unit/g of tissue [21]. 
Biochemical assay of glucose-6-phosphate dehydrogenase activity 
The glucose-6-phosphate dehydrogenase activity was measured 
spectrophotometrically following the standard method [22]. Tissue 
was homogenized in ice-cold 0.1 M phosphate buffer saline (pH-7.4) 
at the tissue concentration of 50 mg/ml. In spectrophotometric 
cuvette, 0.3 ml of 1M Tris chloride buffer (pH-7.5), 0.3 ml of 2.5×10-
2 M glucose-6-phosphate, 0.1 ml of 2×10-3 M NADP and 0.3 ml of 0.2 
M MgCl2 and 0.3 ml of ice cold tissue homogenate were taken. The 
rate of change of absorbance at 340 nm was recorded. One unit of 
enzyme activity define as that quantity which catalyses the 
reduction in 1 μM of NADP per minute. 
Biochemical assay of glucose-6-phosphatase activity 
The hepatic glucose-6-phosphatase activity was measured according 
to standard protocol [23]. Tissue was homogenized in ice cold of 0.1 
M phosphate buffer saline (pH 7.4) at the tissue concentration of 50 
mg/ml. In a calibrated centrifuge tube, 0.1 ml of 0.1 M glucose-6-
phosphate solution and 0.3 ml of 0.5M maleic acid buffer (pH 6.5) 
were taken and brought to 37 °C in water bath for 15 min. The 
reaction was stopped with 1 ml of 10% trichloroacetic acid (TCA) 
followed by chilling in ice and centrifuge at 3000g for10 min. The 
optical density was noted at 340 nm. The enzyme activity was 
expressed as mg of inorganic phosphate liberated per g of tissue. 
Biochemical assay of catalase activity 
For the evaluation of catalase activity, liver and kidney tissues were 
homogenized in 0.05 M Tris-HCl buffer solution (pH-7.0) at the tissue 
concentration of 50 mg/ml. These homogenized samples were 
centrifuged at 10000 × g at 4 °C for 10 min. In spectrophotometer 
cuvette, 0.5 ml of 0.00035 M H2O2 and 2.5 ml of distilled water were 
added and mixed. Readings of absorbance was noted at 240 nm before 
the addition of supernatant. Then, supernatant was added at a volume of 
40 μl to the cuvette and the kinetics was measured by recording 
successive six readings at 30 sec interval. Finally the result was 
expressed as µM of H2O2 consumed/mg of tissue/min [24]. 
Assessment of superoxide dismutase (SOD) activity 
Activity of SOD in the tissue sample was estimated by measuring the 
percentage inhibition in the pyrogallol auto oxidation by superoxide 
desmutase according to standard method [25]. In a 
spectrophotometric cuvette, 2.04 ml of 50 mmol Tris buffer (pH-
8.2), 20 μl of sample and 20 μl of pyrogallol were taken and the 
absorbance was observed in spectrophotometer at 420 nm for 3 
min. One unit of superoxide was defined as the enzyme activity that 
inhibits the auto oxidation of pyrogallol by 50%. 
Estimation of lipid peroxidation from the concentration of 
thiobarbituric acid reactive substances (TBARS) and conjugated di-
ene (CD) 
Tissues were homogenized at the concentration of 50 mg/ml in 0.1 M of 
ice-cold phosphate buffer (pH-7.4) and the homogenates were 
centrifuged at 10000 × g at 4 °C for 5 min. Each supernatant was used for 
the estimation of TBARS and CD. For the measurement of TBARS, the 
homogenate mixture of 0.5 ml was mixed with 0.5 ml of normal saline 
(0.9 g % NaCl) and 2 ml of TBA-TCA mixture (0.392 g thiobarbituric acid 
in 75 ml of 0.25(N) HCl with 15 gm trichloroacetic acid. The volume of 
the mixture was made up to 100 ml by 95 % ethanol and boiled at 100 °C 
for 10 min. This mixture was then cooled at room temperature and 
centrifuged at 4000 × g for 10 min. The whole supernatant was 
transferred in spectrophotometer cuvette and read at 535 nm [26]. 
Quantification of the CD was performed by standard method [27]. The 
lipids were extracted with chloroform-methanol (2:1) mixture followed 
by centrifugation at 1000 × g for 5 min. The chloroform layer was 
evaporated to dryness under a stream of nitrogen. The lipid residue was 
dissolved in 1.5 ml of cyclohexane and the absorbance was noted at 233 
nm to measure the amount of hydro peroxide formed. 
RNA isolation and complementary DNA synthesis 
Whole existing RNA in hepatic tissue was extracted using kit (Roche 
Diagnostic, Mannheiem, Germany), and from that extracted RNA, 
cDNA was synthesised using ‘Transcriptor First Strand cDNA 
Synthesis Kit’ (Roche Diagnostic) [28]. 
Quantitative reverse transcription polymerase chain reaction 
(qRT-PCR) analysis 
For the evaluation of gene expression of Hexokinase-I, SOD, Bax, Bcl-
2 and β-actin genes of hepatic tissues by using Light Cycler 480 II 
(Roche Diagnostic) was used [28]. 
Statistical analysis 
Analysis of Variance (ANOVA) followed by ‘Multiple comparison 
two-tail‘t’ test’ was used for statistical analysis of collected data [29]. 
All the values were indicated by mean±SEM, (n = 6). For statistical 
analysis of data, differences were considered significant at p<0.05. 
RESULTS 
Fasting blood glucose level 
Fasting blood glucose level was significantly elevated (p<0.05) in 
STZ-induced diabetic rats in respect to vehicle treated control group. 
Treatment of ethyl acetate fraction of aqueous-methanol: : 40:60 
extract of seed of M. fragrans at the dose of 10 mg or 20 mg or 40 
mg/100 g of body weight for 28 d to the diabetic rats resulted a 
significant diminution (p<0.05) in FBG level when comparison was 
made with vehicle treated diabetic group. From the comparative 
analysis of the data it was observed that 20 mg or 40 mg fraction 
treated group resulted a significant diminution (p<0.05) of fasting 
blood glucose level in respect to 10 mg fraction treated diabetic 
animals though no significant variation was noted in the level of the 
said parameter between 20 mg and 40 mg fraction treated diabetic 
groups indicated that 20 mg dose is the threshold dose in this 
concern (table 1). 
 
Table 1: Dose dependent effect of ethyl acetate fraction of seed of M. fragrans on FBG level in STZ-induced diabetic male albino rat 
Group Fasting blood glucose level (mg/dl) 
1st d (7th d of STZ injection) 8th d 15th d 22nd d 28th d 
Vehicle treated control  70.21±2.8a 71.07±3.1a 69.19±3.3a 72.21±3.1a 71.71±2.6a 
Vehicle treated diabetic  329.02±4.6b 334.51±5.1b 337.12±5.6b 337.17±4.8b 339.24±4.2b 
Ethyl acetate fraction 10 mg 333.3±4.6b 337.91±5.1b 332.42±3.8b 319.14±3.5b 216.24±4.4c 
Ethyl acetate fraction 20 mg 337.54±4.3b 236.42±4.2d 176.24±3.4d 136.12±3.8d 114.09±2.1d 
Ethyl acetate fraction 40 mg 334.71±4.2b 252.02±4.4d 208.91±4.6d 152.21±4.5d 146.91±3.6d 
Value represents mean±SEM (n=6). Values with different superscripts (a, b, c, d) in each vertical column differ from each other significantly, p<0.05. 
 
Serum insulin 
Serum insulin level was decreased significantly (p<0.05) in STZ-
induced diabetic group in respect to vehicle treated control group. 
Ethyl acetate fraction of aqueous-methanol: : 40:60 extract of seed of 
M. fragrans treatment to diabetic animals at the dose of 10 mg or 20 
mg or 40 mg/100 g of body weight for 28 d resulted a significant 
elevation (p<0.05) in serum insulin level when compare with vehicle 
treated diabetic group. After comparison of the data among different 
fraction treated groups it was observed that 20 mg or 40 mg/100 g 
of body weight showed more promising results than other fractions 
treated groups though the level of serum insulin was not resettled to 
the control level. Insignificant variation in serum insulin level was 
noted between 20 mg and 40 mg/100 g of body weight fraction 
treated diabetic groups which suggest the threshold dose in this 
concern is 20 mg/100 g body weight (fig. 1). 
 
 
Fig. 1: Significant recovery in the level of serum insulin after administration of ethyl acetate fraction of seed of M. fragrans at different 
dose treated groups in STZ-induced diabetic rat. Bars were expressed as mean±SEM (n=6). Bars with different superscripts (a, b, c, d) 
differ from each other significantly, p<0.05 
 
Activities of hexokinase and glucose-6-phosphate dehydrogenase 
in liver and skeletal muscle 
Activities of hexokinase and glucose-6-phosphate dehydrogenase in 
liver and skeletal muscle tissues were diminished significantly 
(p<0.05) in STZ-induced diabetic group in compare with the vehicle 
treated control group. After the treatment of ethyl acetate fraction of 
seed of M. fragrans at the dose of 10 mg or 20 mg or 40 mg/100 g of 
body weight for 28 d to the STZ-induced diabetic animals resulted a 
significant elevation (p<0.05) in the activities of these enzymes in 
respect to vehicle treated diabetic group. Results focused that 20 mg 
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mg dose of ethyl acetate fraction though the levels of the said 
sensors were not resettled to the control level. There was no 
significant variation in the levels of these parameters between 20 
mg and 40 mg/100 g of body weight fraction treated diabetic groups 
(fig. 2). 
Assessment of glucose-6-phosphatase activity 
Activities of glucose-6-phosphatase in hepatic and skeletal muscular 
tissues were increased significantly (p<0.05) in the diabetic animals 
in compare with the vehicle treated control animals. Vehicle treated 
diabetic animals treated with different dose of ethyl acetate fraction 
of seed of M. fragrans resulted a significant diminution (p<0.05) in 
the activities of glucose-6-phosphatase in respect to the vehicle 
treated diabetic group. Comparative analysis of the data in the 
activities of the enzyme indicated that 20 mg and 40 mg/100 g of 
body weight dose treated group showed significant effective result 
(p<0.05) in compare with 10 mg/100 g of body weight dose treated 
group. There was no significant variation in the levels of these 
parameters between 20 mg and 40 mg /100 g of body weight 





Fig. 2: Resettlement in the activities of hexokinase, glucose-6-phosphate dehydrogenase and glucose-6-phosphatase in liver and skeletal 
muscle after treatment of ethyl acetate fraction of aqueous-methanol extract of seed of M. fragrans at different doses in vehicle treated 
diabetic rat. Values were expressed as mean±SEM, n=6. Bars with different superscripts (a, b, c, d) differ from each other significantly, 
p<0.05 
 
Catalase and SOD activities in liver and kidney tissues 
Activities of catalase and SOD in liver and kidney tissues were 
significantly diminished (p<0.05) in STZ treated diabetic group in 
compare with the vehicle treated control group. Administration of ethyl 
acetate fraction of seed of M. fragrans at the dose 10 mg/100g of body 
weight for 28 d to the diabetic rats resulted a significant elevation 
(p<0.05) in the activities of catalase and SOD in liver and kidney tissues 
in compare with vehicle treated diabetic group. In contrast, after 28 d 
treatment of said fraction at the dose of 20 mg or 40 mg/100g body 
weight to diabetic rats, a significant recovery (p<0.05) was noted in the 
activities of the concerned parameters in respect to other doses of ethyl 
acetate fraction. The levels of these parameters were insignificantly 
differed when the results were compared between 20 mg and 40 
mg/100 g of body weight fraction treated groups though the levels were 
not resettled to the control level (fig. 3). 
Quantification of TBARS and CD in liver and kidney tissues 
Quantity of TBARS and CD were significantly increased (p<0.05) in 
liver and kidney tissues of STZ induced diabetic group in respect to 
the vehicle treated control group. Treatment of ethyl acetate fraction 
of seed of M. fragrans at the dose of 10 mg or 20 mg or 40 mg/100 g 
body weight/day for 28 d to the diabetic rats resulted a significant 
diminution (p<0.05) in the levels of these parameters in respect to 
the vehicle treated diabetic group. A significant recovery (p<0.05) 
was observed in 20 mg or 40 mg fraction treated group in compare 
with 10 mg fraction treated group though the levels were 
significantly less (p<0.05) than the control level. There was no 
significant difference between 20 mg and 40 mg/100 g of body 
weight fraction administered groups in the levels of TBARS and CD 
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Fig. 3: Amelioration in the activities of catalase and SOD in hepatic and renal tissue after treatment with ethyl acetate fraction of hydro-
methanol extract of seed of M. fragrans at different doses in STZ-induced diabetic rat. Values were expressed as Mean ± SEM, n=6. Bars 




Fig. 4: Remedial effect of ethyl acetate fraction of seed of M. fragrans at different doses on TBARS and CD levels in hepatic and renal 
tissues in comparison to the vehicle treated diabetic rat. Values were represented mean±SEM (n=6). Bars with different superscripts (a, b, 
c, d) differ from each other significantly, p<0.05 
 
Gene expression pattern of hexokinase-1, SOD, Bax, Bcl-2 in 
hepatic tissue 
Hexokinase-1, SOD and Bcl-2 gene expression levels were 
decreased significantly (p<0.05) in vehicle treated diabetic rats 
and this genetic levels were further resettled after ethyl acetate 
fraction of seed of M. fragrans treatment to the diabetic rats at the 
dose of 10 mg or 20 mg or 40 mg/100 g body weight/day for 28 d. 
Gene level of Bax was significantly increased (p<0.05) in vehicle 
treated diabetic group and it was further recovered in different 
doses fraction treated groups. A significant recovery (p<0.05) was 
noted in 20 mg or 40 mg fraction treated group in contrast with 10 
mg fraction treated group though the levels were significantly less 
(p<0.05) than the control level. There was no significant difference 
between 20 mg and 40 mg/100 g of body weight fraction 
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Fig. 5.1: Line diagram of qRT-PCR analysis of gene expression of hexokinase-I in hepatic tissue after administration of ethyl acetate 
fraction of aqueous-methanol (40:60) extract of seed of M. fragrans in diabetic animals. Values were expressed as mean±SEM (n=6). 
Values with different superscripts (a, b, c, d) differ from each other significantly, p<0.05 
 
 
Fig. 5.2: Gene expression pattern of SOD in hepatic tissue after oral administration of ethyl acetate fraction of aqueous-methanol (40:60) 
extract of seed of M. fragrans to vehicle treated diabetic rat. Values were expressed as mean±SEM, n=6. Values with different superscripts 
(a, b, c, d) differ from each other significantly, p<0.05 
 
 
Fig. 5.3: Investigation of Bax, Bcl-2 gene expression through qRT-PCR in hepatic tissue after treatment with ethyl acetate fraction of 
aqueous-methanol (40:60) extract of seed of M. fragrans to vehicle treated diabetic rat. Values were expressed as mean±SEM, n=6. Values 





























































































































































The dose dependent study has been performed to find out the 
threshold dose of ethyl acetate fraction of seed of M. fragrans for the 
management of diabetic disorders in STZ-induced diabetic rats. 
Three different doses i.e. 10 mg, 20 mg dose and 40 mg were 
adopted in the present study where 20 mg showed effective 
diminution of FBG level in respect of vehicle treated diabetic rats. So, 
it may be stated that the extract stimulates the β-cells of pancreas 
for the secretion of insulin or it has the capacity for restoration of 
pancreatic β-cells as observed by others, using separate plant 
products [30]. The above findings have been further supported from 
the outcome of serum insulin level which was increased by the 
treatment of ethyl acetate fraction of seed of M. fragrans at the dose 
of 20 mg and 40 mg/100 g of body weight in respect to diabetic 
animal. The dose at the level of 20 mg and 40 mg/100 g of body 
weight of ethyl-acetate fraction of M. fragrans seed showed most 
effective outcome in respect to 10 mg dose/100 g of body weight. 
The view for the regenerative activities of this fraction for pancreatic 
β-cell in STZ-induced diabetes has been reflected here from the 
recovery in the activities of hexokinase, glucose-6-phosphate 
dehydrogenase and glucose-6-phosphatase in liver and skeletal 
muscle as the enzyme hexokinase and glucose-6-phosphate 
dehydrogenase are regulated by insulin in positive way and glucose-
6-phosphatase in negative way [31, 32]. Activities of catalase and 
SOD were decreased in hepatic and kidney tissues in diabetic 
condition and recovered significantly by fraction treatment. The said 
recovery may be due to the antioxidant activity of the phytomolecule 
(s) present in said extract which protects the catalytic protein 
molecules in cells from diabetes-induced reactive oxygen species bio-
molecule injury [33]. This antioxidative activity has been 
strengthen here from the quantification of TBARS and CD levels 
in above said tissues as there is an inverse relationship between 
the activities of antioxidant enzymes and quantity of free radical 
byproducts which is consistent with other report [34] as well as 
by our previous works [35, 36]. All these deformities were 
corrected by the fraction treatment which may be due to 
recovery in serum insulin [37]. Gene expressions of hexokinase-I 
in hepatic tissue was assessed to find out the molecular 
mechanism of the fraction. The positive regulation of 
hexokinase-I gene may be due to higher level of serum insulin as 
hexokinase-I expression pattern is modulated by insulin in 
positive way. In the present study, STZ-induced diabetic animals 
showed a significant reduction in the gene expression of 
superoxide dismutase and the genomic activities were 
significantly recovered after treatment of different doses 
fraction in comparison to diabetic animals. This remedial effect 
of the fraction may be due to the stimulation of this fraction on 
the existing β-cell or regeneration of the β-cell for the recovery 
in serum insulin and ultimately protecting the cell from 
apoptosis which was further established by apoptotic markers. 
Gene expression pattern of Bax and Bcl-2 from diabetic state 
towards the vehicle treated control may be due to effect of the 
fraction on the concern gene [38]. After the treatment of 
different doses of ethyl acetate fraction to diabetic animals it 
was noted that 20 mg dose is the threshold dose because 
maximum recovery was observed at this lowest dose [39]. From 
the comparative analysis of the data, it is observed that 20 mg 
dose results most promising results in this concern. 
CONCLUSION 
From the results of this experiment it may be concluded that 20 mg 
dose of the said fraction of seed of M. fragrans is the threshold dose for 
the management of diabetic disorders with special reference to 
carbohydrate metabolic and oxidative stress recovery by regeneration 
of β-cells in pancreas and by stimulating gene expression of 
carbohydrate metabolic enzymes as well as by recovery of decreasing 
oxidative stress which may lead to development of herbal drug for 
such management.  
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